Muscarinic agonist inhibition of rat striatal adenylate cyclase is enhanced by dopamine stimulation

Life Sciences

Volumn 59, Issue 7, 1996, Pages 565-572

  Delapp, Neil W ^a   Eckols, Kris ^a   Harlan, E ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

adenylate cyclase; dopamine D1; muscarinic M4; striatum

Indexed keywords

4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; 4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADENYLATE CYCLASE; ATROPINE; BETHANECHOL; CARBACHOL; CYCLIC AMP; DOPAMINE; DOPAMINE 1 RECEPTOR; FORSKOLIN; METHOCTRAMINE; MUSCARINIC AGENT; MUSCARINIC M4 RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; OTENZEPAD; OXOTREMORINE; PHOSPHODIESTERASE INHIBITOR; PIRENZEPINE; RECEPTOR SUBTYPE;

ANIMAL TISSUE; ARTICLE; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DRUG POTENCY; DRUG POTENTIATION; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; NEUROPHARMACOLOGY; NONHUMAN; RAT;

ANIMALIA;

EID: 0030581119     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00337-2     Document Type: Article

References (18)

1. P. G. STRANGE, Prog. Brain Res. 99 167-179 (1993).
2. N. J. BUCKLEY, T. l. BONNER and M. R. BRANN, J. Neurosci. 8 4646-4652 (1988).
3. D. M. WEINER, A. I. LEVEY and M. R. BRANN, Proc. Natl. Acad. Sci. USA 87 7050-7054(1990).
4. M. WAELBROECK, M. TASTENOY, J. CAMUS and J. CHRISTOPHE, Mol. Pharmacol. 38 267-273 (1990).
5. R. P. YASUDA, W. CIESLA, L R. FLORES, S. J. WALL, M. LI, S. A. SATKUS, J. S. WEISSTEIN, B. V. SPAGNOLA and B. B. WOLFE, Mol. Pharmacol. 42 149-157 (1993).
6. A. l. LEVEY, C. A. KITT, W. F. SIMONDS, D. L. PRICE and M. R. BRANN, J. Neurosci. H 3218-3226 (1991).
7. M. C. OLIANAS and P. ONALI, J. Pharmacol. Exp. Ther. 259 680-686 (1991).
8. M. MCKINNEY, D. ANDERSON, C. FORRAY and E. E. EL-FAKAHANY, J. Pharmacol. Exp. Ther. 25, 565-572 (1989).
9. F. J. EHLERT, M. DELEN, S. H. YUN, J. FRIEDMAN and D. W. SELF, J. Pharmacol. Exp. Ther. 25J.660-671 (1989).
10. V. BERNARD, E. NORMAND and B. BLOCH, J. Neurosci. 12 3591-3600 (1992).
11. M. C. OLIANAS, P. ONALI, N. H. NEFF and E. COSTA, J. Neurochem. 41 1364-1369 (1983).
12. E. KELLY and S. R. NAHORSKI, J. Neurochem. 47 1512-1516 (1986).
13. O. H. LOWRY, N. J. ROSEBROUGH, A. L FARR and R. J. RANDALL, J. Biol. Chem. 193 265-275 (1951).
14. G. BATTAGLIA, A. B. NORMAN, E.J. HASS and J. CREESE, J. Neurochem 46_11801185(1986).
15. O. H. CHOI, M. T. SHAMIN, W. L. PADGETT and J. W. DALY, Life Sci. 42 387-398 (1988).
16. M. C. OLIANAS and P. ONALI, Mol. Pharm. 22.393-398 (1983).
17. M. MCKINNEY, Prog. Brain Res. 2fi 333-340, (1993).
18. M. MCKINNEY, D. J. ANDERSON, L VELLA-ROUNTREE, T. CONNALLY and J. H. MILLER, J. Pharm. Exp. Ther. 252 1121-1129 (1991).